New Freeze-Dried shot aims to shield seniors from common respiratory virus
NCT ID NCT07289542
Summary
This study is testing a new, freeze-dried mRNA vaccine designed to protect adults aged 50 and older from Respiratory Syncytial Virus (RSV). Researchers are comparing two different dose levels against a placebo to see how well the vaccine triggers an immune response and how safe it is. The goal is to find a preventive option for a virus that can cause serious illness in older adults.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baise Center For Disease Control & Prevention
Baise City, Baise, China
Conditions
Explore the condition pages connected to this study.